Bacterial Pneumonia Clinical Trials

2 recruiting

About Bacterial Pneumonia Clinical Trials

Looking for clinical trials for Bacterial Pneumonia? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Bacterial Pneumonia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Bacterial Pneumonia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Phase 2

A Clinical Trial to Assess the Safety and PK of OMN6 in HABP or VABP Caused by Acinetobacter Baumannii Complex

Hospital-acquired Bacterial PneumoniaVentilator-associated Bacterial Pneumonia
Omnix Medical Ltd54 enrolled5 locationsNCT06087536
Recruiting

A Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Polymyxin B and Colistin Methanesulfonate in Patients With Carbapenem-Resistant Gram-Negative Bacterial Infection

Bacteremia Caused by Gram-Negative BacteriaBacterial Pneumonia
TTY Biopharm480 enrolled1 locationNCT06966284
Recruiting
Phase 3

A Study to Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABP

Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia
Qilu Pharmaceutical Co., Ltd.420 enrolled1 locationNCT07327619
Recruiting
Phase 3

Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections

Hospital-acquired Bacterial Pneumonia (HABP)Ventilator-associated Bacterial Pneumonia (VABP)Complicated Intra-abdominal Infection (cIAI)+2 more
Qilu Pharmaceutical Co., Ltd.80 enrolled1 locationNCT07089186
Recruiting
Phase 4

Efficacy and Safety of Faropenem in Bangladeshi Adult Patients With Community-Acquired Bacterial Pneumonia (CABP)

Pneumonia, Community-AcquiredBacterial Pneumonia
Dr. Md. Alimur Reza160 enrolled2 locationsNCT06804096
Recruiting

Cellular Markers in Treated or Untreated Non-tuberculous Mycobacterial Respiratory Infection in Patients With Cystic Fibrosis

Non-Tuberculous Mycobacterial Pneumonia
University Hospital, Montpellier76 enrolled1 locationNCT06602869
Recruiting
Phase 2

A Trial of HRS-8427 in the Treatment of Adults With Bacterial Pneumonia

Hospital-acquired Bacterial Pneumonia (HABP)Ventilator-associated Bacterial Pneumonia (VABP)
Jiangsu HengRui Medicine Co., Ltd.100 enrolled1 locationNCT06841731
Recruiting

Mycobacteria Registry Study: Prospective Observational Study in Austria

TuberculosisNon-Tuberculous Mycobacterial Pneumonia
Ludwig Boltzmann Institute for Lung Health1,000 enrolled3 locationsNCT06522347
Recruiting
Phase 3

A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP

Community-acquired Bacterial Pneumonia
Zai Lab (Hong Kong), Ltd.100 enrolled40 locationsNCT06162286
Recruiting

Identification of New Biological Markers for the Progression of Mycobacterium Abscessus-induced Lung Disease in Cystic Fibrosis

Non-Tuberculous Mycobacterial PneumoniaCystic Fibrosis Lung
Ospedale San Raffaele40 enrolled1 locationNCT06413459
Recruiting

Development of a Canadian Bronchiectasis and NTM Database

BronchiectasisNon-Tuberculous Mycobacterial Pneumonia
University of Calgary2,000 enrolled1 locationNCT06144996